Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study

被引:2
作者
Ye, Wanlu [1 ]
Wang, Qing [1 ]
Lu, Yanming [1 ]
机构
[1] China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang 110003, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Ovarian endometrioid carcinoma; SEER database; Nomogram; Prognosis; Treatment; CANCER; LYMPHADENECTOMY; WOMEN; RISK;
D O I
10.1007/s00432-023-05172-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundOvarian endometrioid carcinoma (OEC) is the second most commonly occurring ovarian epithelial malignancy, but the associated prognostic factors remain obscure. This study aimed to analyze independent prognostic factors for patients with OEC and to develop and validate a nomogram to predict the overall survival (OS) of these patients.MethodsClinical information of patients with OEC (2000-2019) was obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox analyses were used to identify independent prognostic factors, and nomogram models were constructed using independent prognostic factors. Receiver operating characteristic (ROC) curve, calibration plots, and decision curve analysis (DCA) were used to verify the accuracy and validity of the nomogram. Kaplan-Meier curves were used to compare the differences in OS and cancer-specific survival (CSS) among subgroups.ResultsA total of 4628 patients with OEC were included, being divided into training (n = 3238) and validation (n = 1390) sets (7:3 ratio). On multivariate Cox analysis, AJCC stage, age, tumor size, differentiation, chemotherapy, and lymph node resection were significant predictors of survival outcomes (P < 0.05). Resection of 1-3 lymph nodes in early-stage OEC patients did not significantly prolong OS (P > 0.05), but resection of & GE; 4 lymph nodes in early-stage improved OS and CSS (P < 0.05). The OS of early-stage patients was not related to whether or not they received chemotherapy (P > 0.05). Lymph node resection and chemotherapy significantly improved the prognosis of patients with advanced OEC (P < 0.05). The c-index of nomogram prediction model was 0.782. ROC with good discrimination, calibration plots with high consistency, and DCA with large net benefit rate result in large clinical value.ConclusionAJCC stage, differentiation, tumor size, age, chemotherapy, and lymph node dissection were prognostic factors of OEC. The constructed nomogram prediction model can effectively predict the prognosis of OEC patients and improve the accuracy of clinical decision-making.
引用
收藏
页码:13607 / 13618
页数:12
相关论文
共 32 条
  • [1] High-grade Endometrioid Carcinoma of the Ovary A Clinicopathologic Study of 30 Cases
    Assem, Hisham
    Rambau, Peter F.
    Lee, Sandra
    Ogilvie, Travis
    Sienko, Anna
    Kelemen, Linda E.
    Kobel, Martin
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (04) : 534 - 544
  • [2] Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues
    Bentivegna, E.
    Gouy, S.
    Maulard, A.
    Pautier, P.
    Leary, A.
    Colombo, N.
    Morice, P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (11) : 1994 - 2004
  • [3] cancer, Surveillance, Epidemiology, and End Results (SEER) Program
  • [4] De Nonneville A, 2021, CLINICOPATHOLOGICAL
  • [5] Metabolic changes in pelvic lesions: Findings at proton MR spectroscopic imaging
    Hascalik, S
    Celik, O
    Sarac, K
    Meydanli, MM
    Alkan, A
    Mizrak, B
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2005, 60 (03) : 121 - 127
  • [6] The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma
    Ju, U. Chul
    Kang, Woo Dae
    Kim, Seok Mo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (02) : 177 - 183
  • [7] Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis
    Kim, H. S.
    Kim, T. H.
    Chung, H. H.
    Song, Y. S.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (07) : 1878 - 1890
  • [8] Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
    Kraemer, Pauline
    Talhouk, Aline
    Brett, Mary Anne
    Chiu, Derek S.
    Cairns, Evan S.
    Scheunhage, Daniella A.
    Hammond, Rory F. L.
    Farnell, David
    Nazeran, Tayyebeh M.
    Grube, Marcel
    Xia, Zhouchunyang
    Senz, Janine
    Leung, Samuel
    Feil, Lukas
    Pasternak, Jana
    Dixon, Katherine
    Hartkopf, Andreas
    Kraemer, Bernhard
    Brucker, Sara
    Heitz, Florian
    du Bois, Andreas
    Harter, Philipp
    Kommoss, Felix K. F.
    Sinn, Hans-Peter
    Heublein, Sabine
    Kommoss, Friedrich
    Vollert, Hans-Walter
    Manchanda, Ranjit
    de Kroon, Cornelis D.
    Nijman, Hans W.
    de Bruyn, Marco
    Thompson, Emily F.
    Bashashati, Ali
    McAlpine, Jessica N.
    Singh, Naveena
    Tinker, Anna, V
    Staebler, Annette
    Bosse, Tjalling
    Kommoss, Stefan
    Kobel, Martin
    Anglesio, Michael S.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (20) : 5400 - 5410
  • [9] Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
    Le Page, Cecile
    Rahimi, Kurosh
    Kobel, Martin
    Tonin, Patricia N.
    Meunier, Liliane
    Portelance, Lise
    Bernard, Monique
    Nelson, Brad H.
    Bernardini, Marcus Q.
    Bartlett, John M. S.
    Bachvarov, Dimcho
    Gotlieb, Walter H.
    Gilks, Blake
    McAlpine, Jessica N.
    Nachtigal, Mark W.
    Piche, Alain
    Watson, Peter H.
    Vanderhyden, Barbara
    Huntsman, David G.
    Provencher, Diane M.
    Mes-Masson, Anne-Marie
    [J]. BMC CANCER, 2018, 18
  • [10] Leskela S, 2020, AM J SURG PATHOL, V44, P982, DOI 10.1097/PAS.0000000000001478